- Home
- CISO vs CALC Comparison
CISO vs CALC Comparison
Compare CISO & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- CALC
- Stock Information
- Founded
- CISO 2015
- CALC 2011
- Country
- CISO United States
- CALC United States
- Employees
- CISO 402
- CALC N/A
- Industry
- CISO Computer Software: Prepackaged Software
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- CALC Health Care
- Exchange
- CISO Nasdaq
- CALC Nasdaq
- Market Cap
- CISO 12.4M
- CALC 36.0M
- IPO Year
- CISO N/A
- CALC N/A
- Fundamental
- Price
- CISO $1.05
- CALC $2.35
- Analyst Decision
- CISO
- CALC Strong Buy
- Analyst Count
- CISO 0
- CALC 5
- Target Price
- CISO N/A
- CALC $18.20
- AVG Volume (30 Days)
- CISO 151.1K
- CALC 31.5K
- Earning Date
- CISO 04-15-2025
- CALC 03-27-2025
- Dividend Yield
- CISO N/A
- CALC N/A
- EPS Growth
- CISO N/A
- CALC N/A
- EPS
- CISO N/A
- CALC N/A
- Revenue
- CISO $54,633,909.00
- CALC N/A
- Revenue This Year
- CISO $78.76
- CALC N/A
- Revenue Next Year
- CISO N/A
- CALC N/A
- P/E Ratio
- CISO N/A
- CALC N/A
- Revenue Growth
- CISO 34.87
- CALC N/A
- 52 Week Low
- CISO $0.26
- CALC $2.05
- 52 Week High
- CISO $3.84
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- CISO 44.67
- CALC 35.06
- Support Level
- CISO $0.98
- CALC $2.36
- Resistance Level
- CISO $1.15
- CALC $2.66
- Average True Range (ATR)
- CISO 0.11
- CALC 0.24
- MACD
- CISO 0.04
- CALC -0.02
- Stochastic Oscillator
- CISO 24.90
- CALC 4.13
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.